15
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Therapeutic Results from the Trials Managed by the French Cooperative Group on Chronic Lymphocytic Leukemia

Pages 83-88 | Published online: 01 Jul 2009

References

  • Binet J.-L., Auquier A., Dighiero G., Chastang Cl., Piguet H., Coasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat Cl., Boivin P., Lesty C., Duault M.-T., Monconduit M., Belabbes S., Gremy F. A new prognostic classification on Chronic Lymphocytic Leukemia derived from a multivariate analysis. Cancer 1981; 48: 198–206
  • Chastang Cl., Travade Ph., Auquier A. Critical discussion of the assessment of a three-stage prognostic classification for Chronic Lymphocytic Leukemia. Statist in Med 1985; 4: 287–293
  • French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of Chlorambucil and Therapeutic decision in initial forms of Chronic Lymphocytic Leukemia (stage A): Results of a randomized clinical trial on 612 patients. Blood 1990a; 75: 1414–1421
  • French Cooperative Group on Chronic Lymphocytic Leukaemia. Natural history of stage A chronic lymphocytic leukaemia in untreated patients. Br. J. Haematol. 1990b; 76: 45–57
  • Montserrat E., Vinolas N., Reverter J., Rozman C. Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouvelle Revue Française d'Hématologie 1988; 30: 359–361
  • French Cooperative Group on Chronic Lymphocytic Leukaemia. Benefit of the CHOP regimen in advanced untreated chronic lymphocytic leukaemia: Results from a randomized clinical trial. Lancet 1986; i: 1346–1349
  • French Cooperative Group on Chronic Lymphocytic Leukaemia. Long-term results of the CHOP regimen in stage C Chronic Lymphocytic Leukaemia. Br. J. Haematol. 1989; 73: 334–340
  • French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlorambucil versus COP in stage B Chronic Lymphocytic Leukemia. Blood 1990c; 75: 1422–1425

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.